세계의 요실금 케어 용품 시장 : 제품별, 유형별, 사용법별, 성별, 최종사용자별, 지역별 - 예측(-2030년)

The global incontinence care products market is projected to reach USD 20.85 billion by 2030 from USD 14.81 billion in 2025, at a CAGR of 7.1% during the forecast period.

A combination of demographic, medical, and lifestyle forces is fueling the growth of the incontinence care products (ICP) market. A key growth driver is the expanding geriatric population, which is susceptible to urinary & fecal incontinence as a result of age-related diseases. Moreover, new developments in products, such as ultra-thin absorbents, anti-leak barriers, and breathable cloths, are also expected to fuel market growth.

By product, the absorbents segment is expected to register the highest CAGR during the forecast period.

By product, the incontinence care products market is categorized into absorbents and non-absorbents. In 2024, the absorbents segment experienced the highest CAGR during the forecast period. The growth of the absorbents segment is attributed to the rising rate of urinary incontinence, especially in elderly people and women after pregnancy, which requires regular and secure protection. Innovations in the technology of absorbent care, such as the introduction of breathable material and anti-leak designs, are also expected to contribute to market growth.

By type, the urinary incontinence segment is expected to grow at the highest CAGR during the forecast period.

By type, the urinary incontinence segment is categorized into urinary and fecal incontinence. The urinary incontinence segment is the fastest-growing segment during the forecast period. Aging-related weakening of pelvic floor muscles, prostate problems, and hormonal changes following menopause and childbirth are the primary causes of urinary incontinence. Government-sponsored awareness, improved diagnosis rates, and the development of awareness programs in emerging economies also fuel growth in the segment.

In 2024, Europe accounted for the largest market share of the incontinence products market.

The global incontinence care products market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Europe accounted for the largest market share. The region benefits from strong government support, including national health insurance coverage for incontinence products, which significantly boosts adoption, especially in institutional settings like nursing homes and elderly care facilities. The region's leading market players are also expected to drive market growth.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 (27%), Tier 2 (38%), and Tier 3 (35%)
• By Designation: C-level Executives (28%), Director-level Executives (32%), and Others (40%)
• By Region: North America (25%), Europe (40%), the Asia Pacific (32%), Latin America (2%), and the Middle East & Africa (1%)

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.0 billion, Tier 2 = USD 1.0 billion to USD 10.0 billion, and Tier 3 = <USD 1.0 billion.

Note 2: C-level executives include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the incontinence care products market include Essity Aktiebolag (Sweden), Kimberly-Clark Corporation (US), The Procter & Gamble Company (US), PAUL HARTMANN AG (Germany), Ontex BV (Belgium), Unicharm Corporation (Japan), Coloplast A/S (Denmark), Cardinal Health, Inc. (US), Medline Industries, LP (US), McKesson Corporation (US), ABENA A/S (Denmark), Attindas Hygiene Partners Group (US), and Hollister Incorporated (US), among others.

Research Coverage

This report examines the incontinence care products market by focusing on product, type, usage, gender, end user, and region. It also explores the various elements influencing market growth, including drivers, restraints, opportunities, and challenges, while providing insights into the competitive landscape among market leaders. Additionally, the report analyzes micromarkets by assessing their individual growth trends and forecasting the revenue of market segments across five major regions and their respective countries.

Reasons to Buy the Report

The report will help established and new or smaller firms understand the current market trends, allowing them to increase their market share. Companies that purchase the report can implement one or more of the following strategies to enhance their market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (Increasing geriatric population and subsequent rise in chronic conditions, the high prevalence of incontinence, the growing importance & awareness of personal hygiene, the rapid urbanization & rising disposable income, and the increasing cases of obesity), restraints (social stigma associated with incontinence care products, and environmental concerns related to disposal of incontinence products), opportunities (development of bio-based superabsorbent polymers, the increasing adoption of smart diapers, and expansion of home healthcare), and challenges (underreporting of fecal incontinence and disparities in reimbursement for incontinence care products)
• Market Penetration: Complete knowledge of the spectrum of products presented by the leading companies in the incontinence care products market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the incontinence care products market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new products, expanding geographies, and current changes in the incontinence care products industry helps to diversify the market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Essity Aktiebolag (Sweden), Kimberly-Clark Corporation (US), The Procter & Gamble Company (US), PAUL HARTMANN AG (Germany), and Ontex BV (Belgium)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 Growth forecast
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 PARAMETRIC ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 INCONTINENT CARE PRODUCTS MARKET OVERVIEW
• 4.2 EUROPE: INCONTINENT CARE PRODUCTS MARKET, BY PRODUCT (2024)
• 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 INCONTINENT CARE PRODUCTS MARKET: GEOGRAPHICAL MIX
• 4.5 INCONTINENT CARE PRODUCTS MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing geriatric population and subsequent rise in chronic conditions
    • 5.2.1.2 High prevalence of incontinence
    • 5.2.1.3 Growing importance & awareness of personal hygiene
    • 5.2.1.4 Rapid urbanization and rising disposable income
    • 5.2.1.5 Increasing cases of obesity
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Social stigma associated with incontinence care products
    • 5.2.2.2 Environmental concerns related to disposal of incontinence products
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Development of bio-based superabsorbent polymers
    • 5.2.3.2 Increasing adoption of smart diapers
    • 5.2.3.3 Expansion of home healthcare
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Underreporting of fecal incontinence
    • 5.2.4.2 Disparities in reimbursement for incontinence care products
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2022-2O24
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
  • 5.4.3 AVERAGE SELLING PRICE TREND, BY PRODUCT
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 RESEARCH & PRODUCT DEVELOPMENT
  • 5.5.2 RAW MATERIAL PROCUREMENT
  • 5.5.3 MANUFACTURING
  • 5.5.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
• 5.6 SUPPLY CHAIN ANALYSIS
  • 5.6.1 PROMINENT COMPANIES
  • 5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
  • 5.6.3 END USERS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Super Absorbent Polymers (SAPs)
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Sensor technology
• 5.8 PATENT ANALYSIS
• 5.9 TRADE ANALYSIS
  • 5.9.1 TRADE ANALYSIS FOR INCONTINENT CARE PRODUCTS (ABSORBENTS)
    • 5.9.1.1 Import data for HS code 961900
    • 5.9.1.2 Export data for HS code 961900
  • 5.9.2 TRADE ANALYSIS FOR INCONTINENT CARE PRODUCTS (NON-ABSORBENTS)
    • 5.9.2.1 Import data for HS code 901839
    • 5.9.2.2 Export data for HS code 901839
• 5.10 KEY CONFERENCES & EVENTS, 2025-2026
• 5.11 REGULATORY ANALYSIS
  • 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11.2 REGULATORY LANDSCAPE
    • 5.11.2.1 North America
      • 5.11.2.1.1 US
      • 5.11.2.1.2 Canada
    • 5.11.2.2 Europe
    • 5.11.2.3 Asia Pacific
      • 5.11.2.3.1 China
      • 5.11.2.3.2 Japan
      • 5.11.2.3.3 India
      • 5.11.2.3.4 South Korea
    • 5.11.2.4 Latin America
      • 5.11.2.4.1 Brazil
      • 5.11.2.4.2 Mexico
    • 5.11.2.5 Middle East
    • 5.11.2.6 Africa
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.12.2 BARGAINING POWER OF SUPPLIERS
  • 5.12.3 BARGAINING POWER OF BUYERS
  • 5.12.4 THREAT FROM SUBSTITUTES
  • 5.12.5 THREAT FROM NEW ENTRANTS
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 IMPACT OF AI/GENERATIVE AI ON INCONTINENT CARE PRODUCTS MARKET
  • 5.14.1 INTRODUCTION
  • 5.14.2 POTENTIAL OF AI IN INCONTINENT CARE PRODUCTS MARKET
  • 5.14.3 AI USE CASES
  • 5.14.4 KEY COMPANIES IMPLEMENTING AI
  • 5.14.5 FUTURE OF GENERATIVE AI ON INCONTINENT CARE PRODUCTS MARKET
• 5.15 TRUMP TARIFF IMPACT ON INCONTINENT CARE PRODUCTS MARKET
  • 5.15.1 INTRODUCTION
  • 5.15.2 KEY TARIFF RATES
  • 5.15.3 IMPACT OF TARIFFS ON PRICING
  • 5.15.4 KEY IMPACT ON VARIOUS REGIONS
    • 5.15.4.1 North America
    • 5.15.4.2 Europe
    • 5.15.4.3 Asia Pacific
  • 5.15.5 END-USER INDUSTRY IMPACT

6 INCONTINENT CARE PRODUCTS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 ABSORBENTS
  • 6.2.1 PADS & GUARDS
    • 6.2.1.1 Ease of use to drive market
  • 6.2.2 UNDERWEAR & BRIEFS
    • 6.2.2.1 Increased absorbency to fuel demand
  • 6.2.3 BED PROTECTORS
    • 6.2.3.1 Gradual shift towards home-based care to fuel demand
  • 6.2.4 OTHER ABSORBENTS
• 6.3 NON-ABSORBENTS
  • 6.3.1 CATHETERS
    • 6.3.1.1 Intermittent catheters
      • 6.3.1.1.1 Reduced risk of infections to boost market
    • 6.3.1.2 Indwelling catheters
      • 6.3.1.2.1 Rising usage by critically ill patients to boost demand
    • 6.3.1.3 External catheters
      • 6.3.1.3.1 Ease of use to boost demand
  • 6.3.2 DRAINAGE BAGS
    • 6.3.2.1 Increasing rates of catheterization to support market uptake
  • 6.3.3 STIMULATION DEVICES
    • 6.3.3.1 Growing use in home settings to drive market
  • 6.3.4 OTHER NON-ABSORBENTS

7 INCONTINENT CARE PRODUCTS MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 URINARY INCONTINENCE
  • 7.2.1 GROWING PREVALENCE AMONG WOMEN TO DRIVE MARKET
• 7.3 FECAL INCONTINENCE
  • 7.3.1 INCREASE IN GERIATRIC POPULATION TO SUPPORT MARKET GROWTH

8 INCONTINENT CARE PRODUCTS MARKET, BY USAGE

• 8.1 INTRODUCTION
• 8.2 DISPOSABLE
  • 8.2.1 EASY AVAILABILITY AND CONVENIENCE TO DRIVE MARKET
• 8.3 REUSABLE
  • 8.3.1 ENVIRONMENTAL SUSTAINABILITY TO FUEL DEMAND

9 INCONTINENT CARE PRODUCTS MARKET, BY GENDER

• 9.1 INTRODUCTION
• 9.2 FEMALE
  • 9.2.1 HIGHER RATE OF INCONTINENCE DUE TO HORMONAL CHANGES TO PROPEL MARKET
• 9.3 MALE
  • 9.3.1 RISING PREVALENCE OF BPH TO SUPPORT MARKET GROWTH

10 INCONTINENT CARE PRODUCTS MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOME CARE
  • 10.2.1 COST-EFFICIENCY AND HIGH COMFORT TO PROPEL MARKET
• 10.3 HOSPITALS & AMBULATORY SURGERY CENTERS (ASCS)
  • 10.3.1 AVAILABILITY OF CRITICAL CARE SERVICES TO DRIVE DEMAND
• 10.4 OTHER END USERS

11 INCONTINENT CARE PRODUCTS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 EUROPE
  • 11.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.2.2 GERMANY
    • 11.2.2.1 Growing incidence of neurological conditions to boost demand
  • 11.2.3 UK
    • 11.2.3.1 High prevalence of chronic diseases to drive market
  • 11.2.4 FRANCE
    • 11.2.4.1 Large target population to support market growth
  • 11.2.5 ITALY
    • 11.2.5.1 Growing awareness initiatives for urinary & fecal incontinence to fuel market
  • 11.2.6 SPAIN
    • 11.2.6.1 Increasing prevalence of CKD to drive market
  • 11.2.7 REST OF EUROPE
• 11.3 NORTH AMERICA
  • 11.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.3.2 US
    • 11.3.2.1 Rising prevalence of incontinence to drive market
  • 11.3.3 CANADA
    • 11.3.3.1 High incidence of Alzheimer's disease to fuel market
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Rising prevalence of incontinence among women to propel market
  • 11.4.3 JAPAN
    • 11.4.3.1 Established healthcare system and favorable reimbursements to drive market
  • 11.4.4 INDIA
    • 11.4.4.1 R&D initiatives on innovative product development to boost market
  • 11.4.5 SOUTH KOREA
    • 11.4.5.1 Increasing prevalence of Urinary incontinence to boost market
  • 11.4.6 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Advancements in ICP products to support market uptake
  • 11.5.3 MEXICO
    • 11.5.3.1 Rising prevalence of fecal incontinence to support market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
  • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN INCONTINENT CARE PRODUCTS MARKET
• 12.3 REVENUE ANALYSIS, 2022-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Product footprint
    • 12.5.5.4 Type footprint
    • 12.5.5.5 End-user footprint
• 12.6 COMPANY EVALUATION MATRIX: SMES/STARTUPS, 2024
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 STARTING BLOCKS
  • 12.6.3 RESPONSIVE COMPANIES
  • 12.6.4 DYNAMIC COMPANIES
• 12.7 COMPETITIVE SCENARIO
  • 12.7.1 PRODUCT LAUNCHES
  • 12.7.2 DEALS
  • 12.7.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 ESSITY AKTIEBOLAG
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 KIMBERLY-CLARK CORPORATION
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 THE PROCTER & GAMBLE COMPANY
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 MnM view
      • 13.1.3.3.1 Key strengths
      • 13.1.3.3.2 Strategic choices
      • 13.1.3.3.3 Weaknesses & competitive threats
  • 13.1.4 ONTEX BV
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches
      • 13.1.4.3.2 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 PAUL HARTMANN AG
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 MnM view
      • 13.1.5.3.1 Key strengths
      • 13.1.5.3.2 Strategic choices
      • 13.1.5.3.3 Weaknesses & competitive threats
  • 13.1.6 COLOPLAST A/S
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches
      • 13.1.6.3.2 Expansions
  • 13.1.7 UNICHARM CORPORATION
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches
  • 13.1.8 CARDINAL HEALTH, INC
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Expansions
  • 13.1.9 MEDLINE INDUSTRIES, LP
    • 13.1.9.1 Business overview
    • 13.1.9.2 Recent developments
      • 13.1.9.2.1 Deals
  • 13.1.10 MCKESSON CORPORATION
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
  • 13.1.11 ABENA A/S
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Expansions
  • 13.1.12 ATTINDAS HYGIENE PARTNERS GROUP
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product launches
  • 13.1.13 HOLLISTER INCORPORATED
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Expansions
  • 13.1.14 DYNAREX CORPORATION
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
• 13.2 OTHER PLAYERS
  • 13.2.1 CONVATEC GROUP PLC
  • 13.2.2 BECTON, DICKINSON AND COMPANY
  • 13.2.3 DENTSPLY SIRONA
  • 13.2.4 STRYKER CORPORATION
  • 13.2.5 FIRST QUALITY ENTERPRISES, INC.
  • 13.2.6 PRINCIPLE BUSINESS ENTERPRISES, INC.
  • 13.2.7 TZMO SA
  • 13.2.8 PRIMARE INTERNATIONAL LTD.
  • 13.2.9 DRYLOCK TECHNOLOGIES
  • 13.2.10 NORTHSHORE CARE SUPPLY
  • 13.2.11 NOBEL HYGIENE PVT. LTD.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS